| Autor: |
Schranz M; Vienna Clinical Trial Center (VTC), Department of Ophthalmology and Optometry, Medical University of Vienna, 1090 Vienna, Austria.; Department of Ophthalmology and Optometry, Medical University of Vienna, 1090 Vienna, Austria., Sacu S; Vienna Clinical Trial Center (VTC), Department of Ophthalmology and Optometry, Medical University of Vienna, 1090 Vienna, Austria.; Department of Ophthalmology and Optometry, Medical University of Vienna, 1090 Vienna, Austria., Reiter GS; Department of Ophthalmology and Optometry, Medical University of Vienna, 1090 Vienna, Austria., Baratsits M; Vienna Clinical Trial Center (VTC), Department of Ophthalmology and Optometry, Medical University of Vienna, 1090 Vienna, Austria., Desissaire S; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Austria., Pircher M; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Austria., Mylonas G; Department of Ophthalmology and Optometry, Medical University of Vienna, 1090 Vienna, Austria., Hitzenberger C; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Austria., Schmidt-Erfurth U; Vienna Clinical Trial Center (VTC), Department of Ophthalmology and Optometry, Medical University of Vienna, 1090 Vienna, Austria.; Department of Ophthalmology and Optometry, Medical University of Vienna, 1090 Vienna, Austria., Roberts PK; Department of Ophthalmology and Optometry, Medical University of Vienna, 1090 Vienna, Austria. |
| Abstrakt: |
Purpose: To assess retinal function in areas of presumed fibrosis due to neovascular age-related macular degeneration (nAMD), using multimodal imaging and structure-function correlation. Design: Cross-sectional observational study. Methods: 30 eyes of 30 consecutive patients with nAMD with a minimum history of one year of anti-vascular endothelial growth factor therapy were included. Each patient underwent microperimetry (MP), color fundus photography (CFP), standard spectral-domain-based OCT (SD-OCT), and polarization sensitive-OCT (PS-OCT) imaging. PS-OCT technology can depict retinal fibrosis based on its birefringence. CFP, SD-OCT, and PS-OCT were evaluated independently for the presence of fibrosis at the corresponding MP stimuli locations. MP results and morphologic findings in CFP, SD-OCT, and PS-OCT were co-registered and analyzed using mixed linear models. Results: In total, 1350 MP locations were evaluated to assess the functional impact of fibrosis according to a standardized protocol. The estimated means of retinal areas with signs of fibrosis were 12.60 db (95% confidence interval: 10.44-14.76) in CFP, 11.60 db (95% COI: 8.84-14.36) in OCT, and 11.02 db (95% COI 8.10-13.94) in PS-OCT. Areas evaluated as subretinal fibrosis in three (7.2 db) or two (10.1 db) modalities were significantly correlated with a lower retinal sensitivity than a subretinal fibrosis observed in only one (15.3 db) or none (23.3 db) modality ( p < 0.001). Conclusions: CFP, SD-OCT and PS-OCT are all suited to detect areas of reduced retinal sensitivity related to fibrosis, however, a multimodal imaging approach provides higher accuracy in the identification of areas with low sensitivity in MP (i.e., impaired retinal function), and thereby improves the detection rate of subretinal fibrosis in nAMD. |
